BE866492A - Derives de pyridazinone - Google Patents

Derives de pyridazinone

Info

Publication number
BE866492A
BE866492A BE187210A BE187210A BE866492A BE 866492 A BE866492 A BE 866492A BE 187210 A BE187210 A BE 187210A BE 187210 A BE187210 A BE 187210A BE 866492 A BE866492 A BE 866492A
Authority
BE
Belgium
Prior art keywords
pyridazinone derivatives
pyridazinone
derivatives
Prior art date
Application number
BE187210A
Other languages
English (en)
French (fr)
Original Assignee
Rolland Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolland Sa A filed Critical Rolland Sa A
Publication of BE866492A publication Critical patent/BE866492A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C07D237/16—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE187210A 1977-04-28 1978-04-27 Derives de pyridazinone BE866492A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7712888A FR2388799A1 (fr) 1977-04-28 1977-04-28 Derives de pyridazinone, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
BE866492A true BE866492A (fr) 1978-10-27

Family

ID=9190051

Family Applications (1)

Application Number Title Priority Date Filing Date
BE187210A BE866492A (fr) 1977-04-28 1978-04-27 Derives de pyridazinone

Country Status (18)

Country Link
US (1) US4188388A (es)
JP (1) JPS53135993A (es)
AU (1) AU3552678A (es)
BE (1) BE866492A (es)
DD (1) DD135488A5 (es)
DE (1) DE2817649A1 (es)
ES (2) ES469234A1 (es)
FR (1) FR2388799A1 (es)
GB (1) GB1584119A (es)
IE (1) IE46730B1 (es)
IL (1) IL54547A0 (es)
IT (1) IT1111174B (es)
LU (1) LU79520A1 (es)
NL (1) NL7804374A (es)
NZ (1) NZ187085A (es)
PL (1) PL112610B1 (es)
PT (1) PT67958B (es)
ZA (1) ZA782209B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
US8076334B2 (en) * 2007-09-20 2011-12-13 Hoffmann-La Roche Inc. Prodrugs of thyroid hormone analogs
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
PL227639B1 (pl) 2014-05-28 2018-01-31 Werner Kenkel Spolka Z Ograniczona Odpowiedzialnoscia Platforma ekspozycyjna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1913265A1 (de) * 1969-03-15 1970-10-01 Basf Ag Verfahren zur Herstellung von 2-Alkylpyridazoniumverbindungen

Also Published As

Publication number Publication date
IT1111174B (it) 1986-01-13
PT67958A (fr) 1978-05-01
US4188388A (en) 1980-02-12
AU3552678A (en) 1979-11-01
IL54547A0 (en) 1978-07-31
ES469234A1 (es) 1980-05-16
LU79520A1 (fr) 1978-11-28
NZ187085A (en) 1979-12-11
JPS53135993A (en) 1978-11-28
PL206456A1 (pl) 1979-04-23
PL112610B1 (en) 1980-10-31
PT67958B (fr) 1979-11-14
IE780778L (en) 1978-10-28
NL7804374A (nl) 1978-10-31
ES476449A1 (es) 1979-05-16
IT7822754A0 (it) 1978-04-27
FR2388799A1 (fr) 1978-11-24
DD135488A5 (de) 1979-05-09
FR2388799B1 (es) 1980-06-27
DE2817649A1 (de) 1978-11-09
GB1584119A (en) 1981-02-04
ZA782209B (en) 1979-04-25
IE46730B1 (en) 1983-09-07

Similar Documents

Publication Publication Date Title
BE867269A (fr) Derives de thiopropanoylamino-acides
SE7805879L (sv) Mevalonolaktonderivat
PT68458A (pt) Triphenylalkene derivatives
NL7803432A (nl) Aceetamidederivaten.
NO784329L (no) Stilbenderivater.
NL7803296A (nl) Cyclohexaandionderivaten.
SE7803057L (sv) Bensimidazolderivat
SE7711581L (sv) Xantin-derivat
NL7805344A (nl) Aminoalkylbenzeenderivaten.
DK543178A (da) Thiodydantoinderivater
SE7804446L (sv) Tienamycinderivat
NL7800262A (nl) Oxazolinoazetidine derivaten.
SE7805260L (sv) Alkylendiaminderivat
SE7801997L (sv) Dipeptidderivat
BE864809A (fr) Derives de benzodiazepine
SE7804778L (sv) Triazinderivat
SE7800982L (sv) Meta-sulfonamido-bensamid-derivat
NL7801708A (nl) 1-oxadethiacepham-derivaten.
SE7805140L (sv) Bensimidazolderivat
FI783393A7 (fi) 2-imino-imidazolidinderivat
FI780344A7 (fi) Oxadiazolopyrimidinderivat
IT7822754A0 (it) Derivati di piridazinone
NL7808036A (nl) Nitrosoureum derivaten.
FI771209A7 (fi) Inloppslaoda i pappersmaskin foersett med luftbehaollare foer utjaemning av tryckvariationer i massasuspensionstroemmen
FI780343A7 (fi) Oxadiazolopyrimidinderivat